A significant step forward for gout

The Lancet

Volumn 371, Issue 9627, 2008, Pages 1816-1818

  Rainer, Timothy H ^a   Graham, Colin A ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID;

ARTHRALGIA; ARTHROCENTESIS; ARTICLE; BACTERIAL ARTHRITIS; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; GOUT; HUMAN; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

EID: 44349091467     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60775-8     Document Type: Note

References (12)

1. Annemans L., Spaepen E., Gaskin M., et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis (2007) 10.1136/ard.2007.076232 published online Nov 2.
2. Roddy E., Zhang W., and Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol 3 (2007) 443-449
3. Janssens H., Lucassen P., van de Laar F., Janssen M., and van de Lisdonk E. Systemic corticosteroids for acute gout. Cochrane Database Syst Rev 16 (2008) CD005521.
4. Janssens H., Janssen M., van de Lisdonk E., van Riel P., and van Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet 371 (2008) 1854-1860
5. Man C., Cheung T., Cameron P., and Rainer T. Comparison of oral prednisolone and oral indomethacin in the treatment of acute gout-like arthritis: a double-blind, randomised, controlled trial. Ann Emerg Med 49 (2007) 670-677
6. Schumacher Jr. H., Edwards L., Perez-Ruiz F., et al. Outcome measures for acute and chronic gout. J Rheumatol 32 (2005) 2452-2455
7. Odio C., Ramirez T., Arias G., et al. Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr Infect Dis J 22 (2003) 883-888
8. James D. The multisystem adverse effects of NSAID therapy. J Am Osteopath Assoc 99 (1999) S1-S7
9. Rodriguez L.G., and Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343 (1994) 769-772
10. Rodriguez L.G., and Hernandez-Diaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res 3 (2001) 98-101
11. Todd K., Funk K., Funk J., and Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med 27 (1996) 485-489
12. Roddy E., Zhang W., and Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford) 46 (2007) 1441-1444